Home » Newsletters » BioWorld

BioWorld

Jan. 13, 1993

View Archived Issues

MYOTROPHIN TO ENTER PHASE II

CYGNUS DRUG-DELIVERY SYSTEM

FDA'S PLANS TO SPEED DRUG APPROVAL

DEPOTECH RAISES $7.3 MILLION

PERSEPTIVE MARKETS MONITORING DEVICE

OCLASSEN REVIVES IPO

CELGENE COLLABORATION FOR WASTE TREATMENT

BIOGEN GETS PATENT ALLOWANCE FOR HIRULOG

CONTROLLED-RELEASE ANTI-HYPERTENSIVE

IMMUNOGEN FORMS 'PAPER' COMPANY

ANTRIL DATA DUE IN FIRST QUARTER

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld Asia
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...